Literature DB >> 23165777

Differential expression of IGF-1 mRNA isoforms in colorectal carcinoma and normal colon tissue.

Aldona Kasprzak1, Witold Szaflarski, Jacek Szmeja, Małgorzata Andrzejewska, Wiesława Przybyszewska, Elżbieta Kaczmarek, Maria Koczorowska, Tomasz Kościński, Maciej Zabel, Michał Drews.   

Abstract

The insulin-like growth factor (IGF)-1 gene consists of 6 exons resulting in the expression of 6 variant forms of mRNA (IA, IB, IC, IIA, IIB and IIC) due to an alternative splicing. The mechanisms of IGF-1 gene splicing and the role of local expression manifested by IGF-1 mRNA variants in colorectal carcinoma (CRC) have not been extensively investigated. Therefore, the aim of our study was to analyse the expression of IGF-1 mRNA isoforms [A, B, C, P1 (class I) and P2 (class II)], as well as the protein expression in CRC and control samples isolated from 28 patients. The expression of Ki-67 was also analysed and clinical data were obtained. For this purpose, we used quantitative real-time PCR (qPCR) and immunocytochemistry. The expression of mRNAs coding for all splicing isoforms of IGF-1 was observed in every tissue sample studied, with a significantly lower expression noted in the CRC as compared to the control samples. The cytoplasmic expression of IGF-1 protein was found in 50% of the CRC and in ~40% of the non-tumor tissues; however, no significant quantitative inter-group differences were observed. The expression of the IGF-1 gene in the 2 groups of tissues was controlled by the P1 and P2 promoters in a similar manner. No significant differences were detected in the expression of the IGF-1 A and B isoforms; however, their expression was significantly higher compared to that of isoform C. No significant differences were observed between the expression of Ki-67 mRNA in the CRC and control tissue even though the expression of the Ki-67 protein was higher in the CRC compared to the control samples. Ki-67 protein expression was associated with the macroscopic and microscopic aspects of CRC. A significant positive correlation was found between the local production of total mRNA and isoform A and the expression of Ki-67 mRNA, although only in the non-tumor tissues. In CRC samples, the local expression of the total IGF-1 mRNA and all splicing isoforms of IGF-1 mRNA decreased as compared to the normal colon tissues, although however, with conservation of both gene promoter activities and with the continued principal splicing IGF-1 mRNA isoforms.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23165777     DOI: 10.3892/ijo.2012.1706

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  15 in total

Review 1.  The complexity of the IGF1 gene splicing, posttranslational modification and bioactivity.

Authors:  Anastassios Philippou; Maria Maridaki; Spiros Pneumaticos; Michael Koutsilieris
Journal:  Mol Med       Date:  2014-05-07       Impact factor: 6.354

2.  Insulin-like growth factor-1 mRNA isoforms and insulin-like growth factor-1 receptor mRNA expression in chronic hepatitis C.

Authors:  Aldona Kasprzak; Agnieszka Adamek; Wiesława Przybyszewska; Przemysław Pyda; Jacek Szmeja; Agnieszka Seraszek-Jaros; Agata Lanzafame; Anna Surdacka; Iwona Mozer-Lisewska; Maria Koczorowska
Journal:  World J Gastroenterol       Date:  2015-04-07       Impact factor: 5.742

3.  IPF pathogenesis is dependent upon TGFβ induction of IGF-1.

Authors:  Danielle M Hernandez; Jeong-Han Kang; Malay Choudhury; Mahefatiana Andrianifahanana; Xueqian Yin; Andrew H Limper; Edward B Leof
Journal:  FASEB J       Date:  2020-02-17       Impact factor: 5.191

4.  Human IGF1 pro-forms induce breast cancer cell proliferation via the IGF1 receptor.

Authors:  Mauro De Santi; Giosuè Annibalini; Elena Barbieri; Anna Villarini; Luciana Vallorani; Serena Contarelli; Franco Berrino; Vilberto Stocchi; Giorgio Brandi
Journal:  Cell Oncol (Dordr)       Date:  2015-12-23       Impact factor: 6.730

Review 5.  IGF axis and other factors in HPV-related and HPV-unrelated carcinogenesis (review).

Authors:  Julia Durzyńska
Journal:  Oncol Rep       Date:  2014-09-19       Impact factor: 3.906

6.  Discovery of Novel Small Molecule Inhibitors of VEGF Expression in Tumor Cells Using a Cell-Based High Throughput Screening Platform.

Authors:  Liangxian Cao; Marla Weetall; Jenelle Bombard; Hongyan Qi; Tamil Arasu; William Lennox; Jean Hedrick; Josephine Sheedy; Nicole Risher; Peter C Brooks; Panayiota Trifillis; Christopher Trotta; Young-Choon Moon; John Babiak; Neil G Almstead; Joseph M Colacino; Thomas W Davis; Stuart W Peltz
Journal:  PLoS One       Date:  2016-12-16       Impact factor: 3.240

7.  Evidence for the Possible Biological Significance of the igf-1 Gene Alternative Splicing in Prostate Cancer.

Authors:  Anastassios Philippou; Athanasios Armakolas; Michael Koutsilieris
Journal:  Front Endocrinol (Lausanne)       Date:  2013-03-20       Impact factor: 5.555

8.  IGF expression in HPV-related and HPV-unrelated human cancer cells.

Authors:  Julia Durzyńska; Elisabeth Barton
Journal:  Oncol Rep       Date:  2014-07-11       Impact factor: 3.906

9.  Correlation Between IGFs-Related Proteins Expression and Incidence of Colorectal Cancer in Diabetic Patients and Related Mechanisms.

Authors:  Xu Han; Sufang Hou; Aige Yang
Journal:  Med Sci Monit       Date:  2016-03-15

10.  IGF-IEc expression is increased in secondary compared to primary foci in neuroendocrine neoplasms.

Authors:  Krystallenia I Alexandraki; Anastassios Philippou; Georgios Boutzios; Irini Theohari; Michael Koutsilieris; Ioanna Kassiani Delladetsima; Gregory A Kaltsas
Journal:  Oncotarget       Date:  2017-09-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.